Related Experiment Videos
p53 mutations in colorectal cancer.
N R Rodrigues1, A Rowan, M E Smith
1Director's Laboratory, Imperial Cancer Research Fund, Lincolns Inn Fields, London, United Kingdom.
Summary
Overexpression of p53 protein in colorectal cancer is linked to mutations in the p53 gene. While immunohistochemistry detects some mutations, others may be missed, highlighting the importance of molecular analysis in cancer research.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- p53 protein overexpression is observed in about 50% of primary colorectal carcinomas.
- Benign adenomas do not show p53 overexpression, suggesting its role in malignancy.
Purpose of the Study:
- To investigate the molecular basis of p53 protein overexpression in colorectal cancer.
- To correlate p53 protein levels with p53 gene mutations in colorectal cancer cell lines.
Main Methods:
- Immunohistological staining of primary tumors.
- Enzyme-linked immunosorbent assay (ELISA), cell-staining, and immunoprecipitation for p53 protein expression.
- Polymerase chain reaction (PCR) with direct sequencing and chemical-mismatch-cleavage analysis for p53 cDNA mutations.
Main Results:
- Six out of 10 colorectal cancer cell lines showed high p53 protein levels.
- All cell lines with high p53 expression had mutant p53 proteins.
- Point mutations were detected in cell lines with lower p53 expression.
Conclusions:
- p53 overexpression in colorectal cancer is associated with p53 gene mutations.
- Some p53 mutations may not be detectable by immunohistochemical analysis alone.
- p53 gene mutation is a frequent genetic alteration in colorectal cancer development.